Ildong Holdings Co., Ltd. (KRX:000230)
South Korea
· Delayed Price · Currency is KRW 12,430
-400 (-3.12%)
Dec 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Medicine Manufacturing and Sales | 613.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Manufacturing and Sales Growth | 2.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Food | 19.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Food Growth | 58.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetic Medical Devices and Software Development | 12.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetic Medical Devices and Software Development Growth | 26.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advertising Agency | 4.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advertising Agency Growth | -37.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ion Water Purifier | 3.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ion Water Purifier Growth | -27.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Pharmacology Consulting | 2.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Pharmacology Consulting Growth | -10.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Holding Company | 1.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Holding Company Growth | 11.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Platform Service Delivery | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Platform Service Delivery Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Software Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Software Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Device | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Device Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hyaluronic Acid and Filler | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hyaluronic Acid and Filler Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| South Korea | 639.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 2.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Southeast Asia | 3.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 2.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -40.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 11.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 26.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|